Latest Commercialisation News

EBR Systems has kicked off a fully underwritten 1-for-2 entitlement offer priced at $0.38 per CDI, aiming to raise $85.6 million to accelerate commercialisation and manufacturing of its wireless cardiac pacing technology.

CleanSpace Holdings has achieved a major regulatory milestone with European EN 12941 certification for its new AGILE loose-fitting PAPR, positioning the company for growth in its largest market and preparing for imminent Australian approval.

Island Pharmaceuticals is accelerating development of its broad-spectrum antiviral Galidesivir, progressing clinical, regulatory, and manufacturing milestones under the FDA Animal Rule pathway with expanded USAMRIID collaboration and biodefence positioning.

Felix Gold has created Frontier Antimony Refinery Corp., a US-focused refining platform with secured access to military-grade antimony ore from its Treasure Creek Project in Alaska, aiming to address critical supply gaps.

Sierra Nevada Gold (ASX: SNX) has appointed Adam Oehlman as CEO to lead its next growth phase, focusing on advancing a three-rig drilling campaign in Saudi Arabia and trial mining in Nevada.

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.

Imricor Medical Systems has submitted the third of four Premarket Approval modules to the FDA, marking a key step towards US approval of its MR-guided cardiac ablation devices.

Anson Resources and POSCO Holdings have inked a binding agreement for POSCO to design and operate a $7.2 million Direct Lithium Extraction demonstration plant at the Green River Lithium Project in Utah, aiming to validate proprietary lithium extraction technology and strengthen U.S. battery supply chains.

LTR Pharma has locked in Strive Specialties as its exclusive US pharmacy fulfilment partner for ROXUS, marking a critical step towards commercial launch in the US erectile dysfunction market.

NOVONIX has achieved a key milestone by delivering a mass production synthetic graphite anode sample to Panasonic, marking the first such North American production and advancing U.S. battery supply chain ambitions.

Ark Mines has produced high-grade monazite and titanium dioxide products from its Sandy Mitchell heavy mineral concentrate, marking a key step toward commercialising its North Queensland rare earths project.

Micro-X has cleared a critical design review for its Full Body CT system, unlocking a $1.6 million milestone payment from US government partner ARPA-H and moving into prototype manufacturing.